Literature DB >> 2976408

Toxicity of intravitreal injection of foscarnet in the rabbit eye.

S C She1, G A Peyman, J A Schulman.   

Abstract

Foscarnet (sodium phosphonoformate) is an antiviral with a high degree of efficacy against members of the herpes simplex virus family. We studied the toxicity of single doses of intravitreally administered foscarnet in the albino rabbit. Eyes were evaluated clinically and by light microscopy. Data demonstrated that doses ranging from 20 to 1000 micrograms per 0.1 milliliter are nontoxic to the retina, suggesting that foscarnet may be useful in the treatment of acute retinal necrosis and cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2976408     DOI: 10.1007/bf00137142

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  13 in total

1.  Treatment of CMV retinitis in an AIDS patient.

Authors:  J F Acheson; S M Shah; D J Spalton; C Bradbeer; R N Thin
Journal:  Br J Ophthalmol       Date:  1987-11       Impact factor: 4.638

Review 2.  Recent developments in antiviral chemotherapy.

Authors:  M A McKinlay; M J Otto
Journal:  Infect Dis Clin North Am       Date:  1987-06       Impact factor: 5.982

3.  Foscarnet for cytomegalovirus retinitis.

Authors:  D R Singer; T J Fallon; W E Schulenburg; G Williams; J Cohen
Journal:  Ann Intern Med       Date:  1985-12       Impact factor: 25.391

4.  Foscarnet for cytomegalovirus infections.

Authors:  O Ringdén; H Wilczek; B Lönnqvist; G Gahrton; B Wahren; J O Lernestedt
Journal:  Lancet       Date:  1985-06-29       Impact factor: 79.321

Review 5.  The antiherpesvirus action of phosphonoacetate.

Authors:  J A Boezi
Journal:  Pharmacol Ther       Date:  1979       Impact factor: 12.310

6.  Treatment of cytomegalovirus retinopathy in patients with acquired immunodeficiency syndrome. Use of the experimental drug 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine.

Authors:  G N Holland; M J Sakamoto; D Hardy; Y Sidikaro; A E Kreiger; L M Frenkel
Journal:  Arch Ophthalmol       Date:  1986-12

7.  Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies.

Authors: 
Journal:  N Engl J Med       Date:  1986-03-27       Impact factor: 91.245

8.  Varicella zoster virus is a cause of the acute retinal necrosis syndrome.

Authors:  W W Culbertson; M S Blumenkranz; J S Pepose; J A Stewart; V T Curtin
Journal:  Ophthalmology       Date:  1986-05       Impact factor: 12.079

9.  Synergism among BIOLF-62, phosphonoformate, and other antiherpetic compounds.

Authors:  K O Smith; K S Galloway; K K Ogilvie; U O Cheriyan
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

10.  Correlation of susceptibility test results in vitro with response in vivo: ketoconazole therapy in a systemic candidiasis model.

Authors:  A Polak; F C Odds; E Lüdin; H J Scholer
Journal:  Chemotherapy       Date:  1985       Impact factor: 2.544

View more
  4 in total

1.  Combination systemic and intravitreal antiviral therapy in the management of acute retinal necrosis syndrome (an American Ophthalmological Society thesis).

Authors:  Christina J Flaxel; Steven Yeh; Andreas K Lauer
Journal:  Trans Am Ophthalmol Soc       Date:  2013-09

2.  Antiviral effect in human cytomegalovirus-infected cells, pharmacokinetics, and intravitreal toxicology in rabbits of acyclovir diphosphate dimyristoylglycerol.

Authors:  S Shakiba; W R Freeman; M Flores-Aguilar; D Munguia; M Tatebayashi; G Besen; R Amani; C A Wiley; C Vuong; K A Aldern
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

3.  High dose intravitreal foscarnet in the treatment of cytomegalovirus retinitis in AIDS.

Authors:  M Diaz-Llopis; E España; G Muñoz; A Navea; E Chipont; J Cano; J L Menezo; F J Romero
Journal:  Br J Ophthalmol       Date:  1994-02       Impact factor: 4.638

4.  In vitro and in vivo evaluation of benzathine foscarnet microcrystals as a potential intravitreal drug depot.

Authors:  Jiaxing Wang; Yong Tao; Jing Feng; Yidong Niu; Jichao Liu; Yanbin Huang
Journal:  RSC Adv       Date:  2019-07-09       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.